Teva Branded Pharmaceutical Products R&d Llc
Clinical trials sponsored by Teva Branded Pharmaceutical Products R&d Llc, explained in plain language.
-
New schizophrenia shot matches pill in drug levels, early study shows
Disease control CompletedThis study tested a new long-acting olanzapine injection (TV-44749) against the standard olanzapine pill in 153 adults with schizophrenia. The goal was to see if the shot delivers the same amount of medicine into the body as the pill. Researchers also checked for side effects. Th…
Phase: PHASE1 • Sponsor: Teva Branded Pharmaceutical Products R&D LLC • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC
-
New migraine shot shows promise for kids as young as 6
Disease control CompletedThis study tested the long-term safety of a monthly shot called fremanezumab to prevent migraine in children and teens aged 6 to 17. Over 500 participants received the drug for up to 84 months. The goal was to see if the treatment is safe and helps reduce migraine days over time.
Phase: PHASE3 • Sponsor: Teva Branded Pharmaceutical Products R&D LLC • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC
-
Healthy volunteers test new drug formulations in absorption study
Knowledge-focused CompletedThis study tested how well different versions of the drug TEV-56286 are absorbed by the body. 47 healthy adults took single doses of new and reference formulations. The goal was to compare absorption levels and check for safety. Participants were involved for about 70 days, inclu…
Phase: PHASE1 • Sponsor: Teva Branded Pharmaceutical Products R&D LLC • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:50 UTC